Navigation Links
Doctors Wary after Shipman Affair

Since the Shipman affair doctors have wary of treating elderly patients with pain-reducing drugs, according to a new survey.//

In 2000, Dr Harold Shipman was declared guilty of 15 murders, although many believe the true number to be much higher. He took his own life in prison in 2004.

A study conducted by the Small Practices Association on behalf of BBC Radio 4 revealed that since Shipman’s conviction, only one in three GPs keep opiates in the surgery in comparison to the three in five who used to stock them before.

The number of GPs carrying these drugs in their bags has also fallen from seven in ten to approximately four in ten GPs. The study also reported an increased anxiety among doctors, with a quarter of GPs saying that they were more worried about prescribing pain relief in case of accidental overdoes to terminally ill patients.

In addition it was found that a third of GPs have increased their referrals to hospitals, hospices and specialized teams, although half report that there has been no change to their practice and only five per cent have stopped home visits to terminally ill patients.

In response to the survey, Dr John Grenville, who gave evidence for the prosecution in the murder of trial of Dr Shipman as well as is a member of the British Medical Association's GP Committee, sought to downplay the findings.

He stated that doctors should have nothing to fear if they keep themselves up to date with the latest technology and recorded accurately the care they provided for elderly patients.

He said, 'I do not believe that my practice has changed with regard to helping people with terminal illness and trying to relieve their pain. I think that certainly GPs have a concern that if things go wrong they may be under greater scrutiny than they previously were.'

He added, 'But as long as GPs keep themselves up-to-date with the use of controlled drugs, with the guidelines and with the
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Doctors needed urgently in Gujarat
3. Doctors operate upon patients in candlelight- latest from the quake scene
4. Doctors at risk- the ugly side of the noble profession
5. Doctors advice early anemia tests
6. Emphasis to ban Drugs ads by Doctors
7. Doctors not to accept gifts from drug companies
8. Gene testing kit specific for Doctors
9. Doctors warned of fluoride toxicity
10. Doctors decisions are affected by fear of lawsuits- says a study
11. Bihar High Court Intervenes To End Doctors Strike
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors Wary after Shipman Affair

(Date:8/28/2008)...conventional therapy, study found , , TH... a treadmill improves brain function and fitness f...ugh the usual rehabilitation program, a new study ...ts have," said study researcher Dr. Andreas Luft, ...itation at the University of Zurich in Switzerland...
(Date:8/28/2008)...al efforts of the Maryland Medicaid contract, HAR...ional medical,management firm, appointed Lenaye La...or. Dr. Lawyer will oversee all clinical aspects o...unt Valley, Maryland Harrisburg,office., "Dr. Law...yland," said,Alice Stollenwerk Petrulis, MD, FACP,...
(Date:8/28/2008)...d physical, especially for the impaired, study say... -- A new study says that 13 percent of American s...buse. , The University of Chicago researchers ..., being taken advantage of financially (3.5 percen...o found that seniors with physical impairments wer...
(Date:8/28/2008)...ding dermatology company serves growing profession... Palo Alto, CA (PRWEB) August 28, 2008 -...l firm, today announced that together with Mustang...ding a Series A round of financing for Profex.Inc....vested $15.5 million in the round. Profex, a leadi...
Breaking Medicine News(10 mins):Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2Health News:13% of Seniors Report Being Mistreated 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 2Health News:Trident Capital and Mustang Ventures Lead Series A Investment in Profex, Inc. 3
...ricans and others are not taking enough vitamin D,...developing cancer, according to a landmark study c...e. The four-year, randomized study followed 1,17... rural eastern Nebraska.* Participants taking calc...
...-like reactions to newer iodine-containing contras...ildren according to a recent study conducted by r... Center and C.S. Mott Childrens Hospital both in A..., risk associated with iodine-containing contrast ...
...n is used to treat a variety of tumors and the res...helial cell death, which in turn limits oxygen d...ll death. Recently, radiation-induced hypoxia was ...a the activation of new blood vessel formation (an...
...er of those hit by the debilitating Alzheimers acr...gest jump is projected for Asia. At the moment th...atients, at 12.6 million. By 2050, the region wi...orld's 106 million Alzheimer's, researchers at Joh...
Other Medicine News:Health News:Vitamin D Reduces Cancer Risk 2Health News:Newer Contrast Agents Safe for Children 2Health News:Alzheimers Incidence is Set to Quadruple by 2050 2
(Date:8/28/2008)..., Austria, Aug. 28 /- Intercell AG (V...rck & Co., Inc. has initiated a Phase II,clinical ...prevention of,Staphylococcus aureus (S. aureus) in...ntrolled study aims to evaluate the safety and imm...ith end-stage kidney disease on,hemodialysis. This...
(Date:8/27/2008)...ing Research Team Makes Crucial Breakthrough in Ba...inson,s Disease, CHICAGO, Aug. 27 /-...y announced that scientists at The University of N...battle to slow or prevent the onset,of a very comm... researchers have genetically produced the first e...
(Date:8/26/2008)...mpany to present data from landmark SYNTAX clinica...Call/ -- Boston Scientific,Corporation (NYSE: BSX...ajor,events and press announcements at the Europea...from August 30 to September 3 in Munich, Germany.,... the SYNTAX trial,which compares percutaneous cor...
(Date:8/26/2008)..., Mass., Aug. 26 /- Cambridge Researc...ase of the Maestro(TM) EX In,Vivo Imaging System. ...,FLEX technology and becomes the entry-level instr... (Photo: http://www.newscom.com/cgi-bin/prnh/200...gnificant advancement of CRi,s unique,solid-state ...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 1BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 2BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 3Gene Variant Boosts Risk for Stress Related Ischemia 17446 1Gene Variant Boosts Risk for Stress Related Ischemia 17446 2OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 1OHSU Cancer Institute researcher identifies protein that helps predict prostate cancer survival 17442 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 1Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 2Prostate cancer screening program leads to bigger fall in death rates than surrounding areas 17438 3
Equinox is a truly unique approach to cosmetic enhancement contact lenses and is worn as a conventional wear lens.
...nd probe system used together to quantify gene exp... system is a sandwich nucleic acid hybridization a...tion and quantification, by amplifying the reporte...nched DNA allows immediate quantification of targe...
Xsera Rapid HIV-1/2 Antibody Controls are unassayed positive and negative quality control materials used for monitoring the performance of qualitative rapid HIV-1 and HIV-2 test kits.
Clearview Simplify D-dimer test kits
Medicine Products: